Verrica Pharmaceuticals
VRCA | NASDAQ
$3.20
-$0.36 (-10.11%)
At close: Nov 16, 2026, 4:00 PM ET
$3.20
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-10.11%
(1D)Rating
53.5
+4.0 ptsFundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #212/1021 (Top 21%)
Key Statistics
Market Data
Market Cap $68.18M
1D Range
3.16 3.43
52W Range
3.09 9.10
Valuation (TTM)
PE -1.40
PB -11.41
EV/EBITDA -1.64
Valuation (NTM)
Forward PE N/A
Forward PEG -0.04
Price Target $9.00
Cash Flow
FCF Yield -47.0%
SBC Adj. FCF Yield -53.9%
SBC Impact -14.7%
Margins
Gross Margin 81.2%
Operating Margin -183.2%
FCF Margin -140.1%
Growth (CAGR)
Revenue 3Y | 5Y 92.6% |
13.8%
Dil EPS 3Y | 5Y 99.8% |
25.8%
FCF 3Y | 5Y 34.2% |
-5.3%
Returns
ROA -108.7%
ROE -442.8%
ROIC -222.7%
Financial Health
Net Cash
$2.76M
Current Ratio 1.66
Interest Coverage -21.80
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The c...
Sector Healthcare
Industry Biotechnology
Employees 76
IPO Date Jun 15, 2018
Website www.verrica.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 12, 2026
EPS
-$0.58
Miss -16.60%
YoY:
-1833.33% REV
$6.91M
Beat +11.51%
YoY:
-51.80%Next Earnings
Mar 10, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$9.00
Upside
+181.25%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove VRCA